MedTrace Logo

Clinical Trial on the Use of 25-OH -D Vitamin in Haemodialysis Patients

NCT01457001 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 284

Last updated 2016-12-01

No results posted yet for this study

Summary

Multicentric randomized Italian clinical trial, open label, not for profit. To evaluate the efficacy of 25-OH-D vitamin in terms of myocardial infarction, stroke, sudden death, death for other causes in chronic haemodialysis patients. Two arms of treatment: 25-OH-D vitamin per os versus no treatment.

Conditions

  • Chronic Renal Failure

Interventions

DRUG

25-OH-D vitamin

Sponsors & Collaborators

  • Società Italiana di Nefrologia

    collaborator UNKNOWN

  • Italian Society of Nephrology

    lead OTHER

Principal Investigators

  • Luigi Morrone, MD · Società Italiana di Nefrologia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01457001 on ClinicalTrials.gov